| 000 | 01893 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515114936.0 | ||
| 264 | 0 | _c20080811 | |
| 008 | 200808s 0 0 eng d | ||
| 022 | _a0006-8993 | ||
| 024 | 7 |
_a10.1016/j.brainres.2008.03.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Jun | |
| 245 | 0 | 0 |
_aInvolvement of the nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway in the antihyperalgesic effects of bovine lactoferrin in a model of neuropathic pain. _h[electronic resource] |
| 260 |
_bBrain research _cMay 2008 |
||
| 300 |
_a1-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnalgesics _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 |
_aCyclic GMP _xmetabolism |
| 650 | 0 | 4 |
_aCyclic GMP-Dependent Protein Kinases _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHyperalgesia _xdrug therapy |
| 650 | 0 | 4 | _aInjections, Spinal |
| 650 | 0 | 4 |
_aLactoferrin _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNarcotic Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aNeurons, Afferent _xdrug effects |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aPotassium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aPotassium Channels _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Opioid, mu _xdrug effects |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aZhang, Li-Cai | |
| 700 | 1 | _aLv, You-Wen | |
| 700 | 1 | _aJi, Yong | |
| 700 | 1 | _aYan, Xue-Jun | |
| 700 | 1 | _aXue, Jin-Pei | |
| 773 | 0 |
_tBrain research _gvol. 1209 _gp. 1-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainres.2008.03.004 _zAvailable from publisher's website |
| 999 |
_c17904733 _d17904733 |
||